Detalhe da pesquisa
1.
Empagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med
; 388(2): 117-127, 2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331190
2.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Lancet
; 403(10424): 379-390, 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38109916
3.
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE).
J Am Soc Nephrol
; 35(1): 74-84, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38088558
4.
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.
J Am Soc Nephrol
; 35(2): 202-215, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38082486
5.
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association.
Circulation
; 148(24): 1982-2004, 2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37947094
6.
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.
Circulation
; 148(20): 1636-1664, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37807920
7.
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
Circulation
; 148(20): 1606-1635, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37807924
8.
Mind the gap in kidney care: translating what we know into what we do.
Kidney Int
; 105(3): 406-417, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38375622
9.
Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study.
Am J Kidney Dis
; 83(1): 37-46, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657635
10.
Methods Article for a Study Protocol: Study Design and Baseline Characteristics for Aldosterone Synthase Inhibition in Chronic Kidney Disease.
Am J Nephrol
; 55(2): 262-272, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903483
11.
Glomerular hyperfiltration as a therapeutic target for CKD.
Nephrol Dial Transplant
; 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38308513
12.
An update review of post-transplant diabetes mellitus: Concept, risk factors, clinical implications and management.
Diabetes Obes Metab
; 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38558257
13.
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial.
Diabetes Obes Metab
; 26(6): 2128-2138, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38497241
14.
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update.
Ann Intern Med
; 176(3): 381-387, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36623286
15.
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo.
Kidney Int
; 103(4): 772-781, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36738891
16.
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes.
N Engl J Med
; 382(26): 2493-2503, 2020 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32579810
17.
Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease.
Curr Opin Nephrol Hypertens
; 32(4): 377-385, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37195250
18.
Baseline modern medical management in the BEST-CLI trial.
J Vasc Surg
; 78(3): 711-718.e5, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37201761
19.
Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide.
Am J Nephrol
; 54(1-2): 74-82, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754023
20.
Effect of tirzepatide on blood pressure and lipids: A meta-analysis of randomized controlled trials.
Diabetes Obes Metab
; 25(12): 3766-3778, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37700437